Got my rx quickly and customer service is always available to speak with for concerns or questions
However, the exact nature of these benefits will depend on how it is applied

this off-label use is not backed by the same level of controlled human trial evidence as the lipodystrophy indication Known risks and side effects: Injection site reactions, including erythema, pruritus, pain, and bruising at the injection site Arthralgia (joint pain) and peripheral edema (fluid retention), recognized class effects of GH-axis stimulation Increases in blood glucose and reduced insulin sensitivity, with clinical trials showing a higher rate of elevated HbA1c and new-onset hyperglycemia versus placebo Formation of anti-tesamorelin antibodies, reported in a substantial proportion of treated patients, with unclear long-term clinical significance Contraindicated in people with active malignancy, pituitary or hypothalamic disruption, or pregnancy, per FDA labeling Evidence snapshot: The strongest evidence is a set of Phase 3 human randomized controlled trials that supported FDA approval of tesamorelin for reducing visceral abdominal fat in HIV-associated lipodystrophy (approved 2010), plus a separate placebo-controlled human RCT (Baker et al., 2012, Archives of Neurology) showing improved executive function in older adults

This peptide is derived from gastric juice and works by: Increasing growth factors at injury sites (helping joints, tendons, and muscles heal faster) Sealing & healing the gut (excellent for digestion & gut permeability) Reducing chronic inflammation at the cellular level Whether youre recovering from injury, surgery, or gut issues, BPC 157 is something to discuss with your functional medicine doctor
You might have some mild side effects right where the shot was given, like mild pain, swelling, or itching
Administration, Storage, and Practical Considerations In research contexts, GHK-Cu is typically administered as a subcutaneous or topical preparation